Self‐Healing Supramolecular Hydrogels for Tissue Engineering Applications by Saunders, Laura & Ma, Peter X.
 This is the author manuscript accepted for publication and has undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1002/mabi.201800313. 





Self-Healing Supramolecular Hydrogels for Tissue Engineering Applications  
 
 




L. Saunders, Prof. P.X. Ma  
Macromolecular Science and Engineering Center 
University of Michigan  
Ann Arbor, MI, USA 
 
Prof. P.X. Ma 
Biologic and Materials Science 
University of Michigan 
Ann Arbor, MI, USA 
 
Biomedical Engineering 
University of Michigan 
Ann Arbor, MI, USA 
 
Materials Science and Engineering 
 This article is protected by copyright. All rights reserved.- 2 - 
University of Michigan 






Self-healing supramolecular hydrogels have emerged as a novel class of biomaterials that combines 
hydrogels with supramolecular chemistry to develop highly functional biomaterials with advantages 
including native tissue mimicry, biocompatibility, and injectability. These properties are endowed by 
the reversibly cross-linked polymer network of the hydrogel. These hydrogels have great potential 
for realizing yet to be clinically translated tissue engineering therapies. This review presents 
methods of self-healing supramolecular hydrogel formation and their uses in tissue engineering as 
well as future perspectives.  
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1. Introduction  
In recent decades, increasing demand for biomaterials capable of aiding in regeneration or 
replacement of damaged tissue motivated the development of new tissue engineering constructs.[1] 
Due to their unique biocompatibility and biomimetic properties, hydrogels have been widely used in 
many biomedical applications such as contact lenses, wound dressings, and drug delivery vehicles.[2–
4] The properties of hydrogels follow from their structure: namely their highly swollen, hydrophilic 
3D crosslinked polymer network that may be either chemically or physically crosslinked to form a 
material that mimics advantageous properties of the highly hydrated extracellular matrix (ECM) and 
facilitates nutrient and oxygen transport due to its porous structure.[3,5] 
While hydrogels offer many useful properties, the permanent covalent crosslinks in traditional 
hydrogels are often not ideal for tissue engineering applications, considering the dynamic nature of 
tissue regeneration and integration with the host. Tissue engineering has yet to achieve anticipated 
clinical impact, largely due to a failure to integrate with existing vasculature and host tissue.[6] The 
irreversible covalent crosslinks result in a material that is unable to heal after breaking, making such 
hydrogels ineffective in sustaining their function or maintaining their desired mechanical 
properties.[7,8] Covalent crosslinks also constrain the movement of polymer chains in the hydrogel 
bulk, decreasing their flexibility and creating an elastic material, which contrasts with the viscoelastic 
and deformable ECM of native tissue.[9] While hydrogels formed by dynamic covalent crosslinks have 
been investigated for biomedical applications, the reversibility of the linkages can rely on harsh 
conditions such as elevated temperatures[10,11], low pH[12,13], UV light[14–17] or a combination of 
these.[18] Such hydrogels are therefore limited to applications that utilize their harsher crosslinking 
conditions such as cancer therapy, where pH sensitive gelation can occur only in the acidic tumor 
microenvironment.[19] The tissue-specific microenvironment is an important design component of 
effective tissue engineering scaffolds as cells are constantly interacting with, remodeling, and 
moving through the ECM to perform normal functions.[20–22] Recent work has looked into dynamic 
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covalent chemistries including Schiff’s Base, imine crosslinks, and disulfide exchange that would 
allow for cellular remodeling and tunable cleavage of the hydrazone or disulfide linkers.[8,9,15,23–25] 
These gels undergo dynamic chemical degradation while maintaining the bulk properties of the 
hydrogel and have been used primarily as self-healing 3D cell culture substrates. These materials 
often exhibit slower reversibility than their supramolecular counterparts and can require the 
addition of a catalyst,[24] but they have still been used for 3D printing as their shear-thinning and self-
healing behavior makes them desirable candidates for extrusion based printing. [26,27] Compared to 
permanently crosslinked hydrogels, the incorporation of cells into dynamic hydrogels is relatively 
new[9], and work remains to be done towards the development of adaptable covalent hydrogels for 
tissue engineering.   
To achieve properties that remain largely unrealized by covalently crosslinked hydrogels such as self-
healing and reversible linkages, supramolecular hydrogels have been developed that combine the 
unique advantages of hydrogels and supramolecular chemistry.[28] The properties of these hydrogels 
follow from the dynamic nature of their constituents: supramolecular bonding motifs that rely on 
hydrogen bonding, electrostatic interactions, π-π bonding, host-guest interactions, hydrophobic 
interactions, or metal coordination act as dynamic crosslinks between hydrophilic polymers to form 
hydrogels.[29–35] The variety of supramolecular building blocks offers many tools for development of a 
diverse range of biomaterials that offer promise as scaffolds for tissue engineering.[36,37]   
This review will focus on important work that has been done towards development of self-healing 
supramolecular hydrogels for tissue engineering applications, with emphasis on supramolecular 
bonding motifs used for hydrogel formation and recent advances towards their use in regenerative 
medicine. We will conclude by looking forward at important challenges facing the development of 
ideal hydrogels as both scaffolds and drug or biologic delivery vehicles to regenerate, maintain, or 
improve lost or damaged tissue. 
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2. Supramolecular Bonding Motifs  
2.1.  Motivation  
To advance the field of tissue engineering, new biomaterials capable of effective, controlled delivery 
of drugs and biologics, and recapitulation of native tissue properties must be developed. Cells exist 
in vivo within a dynamic, 3D matrix consisting of polysaccharides, ECM biopolymers (proteoglycans 
and proteins), and soluble factors secreted by nearby cells.[38] This 3D environment is critical to 
normal cell function, as it enables important cell behaviors including cell adhesion, proliferation, 
migration, and differentiation.[38–42] Hydrogels have a long history as tools for tissue regeneration and 
3D cell culture as they may be engineered to mimic the desired aspects of the native local ECM 
depending on their intended usage. Early attempts at recapitulation of the ECM included 
hydrolytically cleavable and metalloproteinase (MMP)-cleavable permanently crosslinked but 
dynamic hydrogels. For example, a dynamic MMP-cleavable hydrogel was developed to facilitate cell 
invasion and render the polymer networks degradable by cells to mimic this feature in native tissue, 
however the enzymatic cleavage of the crosslinks is permanent, leading to degradation of the bulk 
material.[43,44] It was shown that both hydrolytically and enzymatically degradable hydrogels were 
favorable over  their static covalent counterparts in in vitro cartilage regeneration.[45] Later efforts 
towards development of dynamic systems included a permanently crosslinked, pH-switchable 
hydrogel to enable repeated self-healing via hydrogen bonding[46], however, the gelation occurs at 
pH≤3 and is therefore limited in its application to tissue engineering. Supramolecular hydrogels have 
emerged as a promising tool for tissue regeneration as they can be biocompatible and recapitulate 
the viscoelastic nature of the ECM better than their elastic, covalently crosslinked counterparts due 
to the presence of dynamic linkages. The resulting viscoelastic and dynamic behavior of these 
linkages are responsible for other advantages such as self-healing and injectability. In addition to 
offering advantageous scaffolding for tissue engineering, supramolecular hydrogels can be 
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engineered to effectively encapsulate, sequester, protect, and deliver cells, biologics, and drugs for 
regenerative medicine.  
Of particular interest are supramolecular hydrogels that can self-heal after damage either 
spontaneously or in the presence of a physiological stimulus.[46] This characteristic extends the 
lifetime of materials and makes them ideal candidates for applications involving repeated 
mechanical stress[47] or injection.[48,49] The dynamic nature of reversible crosslinks responsible for 
self-healing behavior also results in shear-thinning (decrease in viscosity as shear stress increases) 
behavior, leading to injectable hydrogels which have been heavily investigated recently as they 
represent a critical step towards less invasive delivery of therapies.[48,50] The properties of self-
healing supramolecular hydrogels may be selected for and tuned by careful choice of a hydrophilic 
polymer and the supramolecular bonding motif utilized as a physical crosslinker (Table 1).  Ideally, 
hydrogels for tissue engineering should enable cell infiltration as well as encapsulate and deliver 
cells and biologics, and be able to autonomously, rapidly, and repeatedly heal in situ at physiological 
conditions.[51] The most important supramolecular bonding motifs used in hydrogel formation for 
tissue engineering applications, with an emphasis on recent advances, are described below.   
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Supramolecular Category Specific Bonding Motif Section References 
Hydrogen Bonding 
Ureidopyrimidinone 2.2.1 31, 48, 56-67 
Benzene-1,3,5-
tricarboxamide 
2.2.2 59, 68-76 
Others 2.2.3 77, 78 
Macrocyclic Host-Guest and 
Inclusion Complexes 
Cyclodextrin Derivatives 2.3.1 80-96, 98,99 
Stimuli-Responsive 
Cyclodextrins 
2.3.2 100-105, 106-110 
Hydrophobic Interactions 




Electrostatic Interactions  2.5 140-150 
Metal-Ligand Complexation  2.6 20, 151-160 
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2.2. Hydrogen Bonding Motifs  
Hydrogen bonding is an important tool for self-assembly in biological systems as it is responsible for 
nucleobase pairing in DNA and RNA as well as the 3D assembly of proteins.[52] While the strength of a 
single hydrogen ‘bond’ is relatively weak compared to covalent and some other non-covalent 
interactions, multivalent molecules greatly increase the degree of association possible between 
supramolecular moieties.[53] In fact, the cooperative effect of hydrogen bonding is responsible for 
some of the toughest covalent materials known, including Kevlar and silk.[54,55] Hydrogen bonding has 
also been utilized to great effect to generate self-healing permanently crosslinked hydrogels, 
however as was mentioned, the crosslinking occurs at a low pH and therefore is not useful in tissue 
engineering.[46]   
2.2.1. Ureidopyrimidinone 
Multiple hydrogen bonding motifs such as the widely reported quadruple hydrogen bonding motif 
ureidopyrimidinone (UPy), first described in a pioneering work in the 1990s, have been widely 
utilized in supramolecular hydrogels as a driving force for hydrogel formation.[31,56,57] Multiple 
hydrogen bonding units act as both hydrogen bond donors and acceptors and intrinsically increase 
the concentration of hydrogen bonding motifs in solution, leading to increased association between 
supramolecular building blocks. To achieve hydrogel formation in an aqueous environment, inter- 
and intramolecular effects must overcome water competition by either increasing the functionality 
per molecule, the molecule concentration, or using a combination of driving forces. Hydrogel 
formation is realized when a high enough association constant between supramolecular units is 
reached. Above a critical concentration, hydrogen bonding, hydrophobic spacers which protect the 
hydrogen bonding groups from the solvent, and π-π stacking combine to combat competitive water 
and drive hydrogel formation. [58–61] 
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Early work on supramolecular polymer networks formed through UPy interactions found that while 
they exhibited viscoelasticity and shear-thinning behavior, they eroded rapidly in aqueous 
environments due to oligomer dissociation, making them unfavorable materials for stable 
hydrogels.[62–64] More recently, work has been done on preparation of biocompatible UPy-based 
supramolecular hydrogels that are capable of autonomous and spontaneous self-assembly at 
physiologically relevant conditions for tissue engineering purposes.[48]  
 
  




Figure 1. Design of a Dextran-UPy hydrogel for multi-tissue regeneration. a) Schematic illustration of 
Dex-UPy hydrogel formation and the mechanisms of the shear-thinning and self-recovery properties. 
Top: multiple hydrogen bonds of UPy and their dynamic interactions. Bottom: hydrogel network 
formation through UPy hydrogen bonds, the shear- thinning under shear stress and self-recovering 
of the hydrogel. b) Self-integration of the hydrogel pieces to form various structures. Some hydrogel 
disks were dyed pink with rhodamine and the others were left with the original light-yellow color to 
visualize the interfaces. Scale bar = 5 mm. 
Adapted with permission. [41] 2015, Wiley. 
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Minimally invasive injectable hydrogels capable of carrying growth factors and cells offer an 
attractive route to regenerate injured tissues. Injectable, self-healing supramolecular hydrogels 
utilizing UPy interactions have been used as biologic carriers[61,65] and cell-delivery systems[48], and 
have been studied in vivo as minimally invasive protein delivery systems for soft tissues including 
kidney[64], and cardiac[65] regeneration after injury.  For example, a pH-switchable, self-healing UPy-
modified PEG hydrogel was delivered to the myocardium via local catheter injection to fast-release 
growth factors to reduce infarct size[65] and subsequently for sustained-release of angiogenic factors 
to promote cardiac regeneration in a chronic infarct pig model.[66] These hydrogels are also useful for 
hard tissue engineering such as bone and cartilage[48] regeneration. In contrast to the majority of 
hydrogels that utilize telechelic UPy units to induce crosslinking a dextran-based hydrogel with 
multiple pendant UPy units per chain was developed as a cell carrier and drug delivery system that 
does not require the addition of hydrophobic spacers for gelation. This system has been used to 
carry chondrocytes, bone marrow stem cells, and bone morphogenetic protein 2 (BMP-2) in an 
integrated construct to induce seamless osteochondral tissue complex regeneration in an in vivo 
mouse model (Figure 1).[48] 
Its self-healing and shear-thinning nature allows possible cell migration and dynamic tissue 
modeling/remodeling following injection, and it represents an important step towards clinically 
relevant self-healing hydrogels for multi-tissue organ regeneration. (Figure 2).  
Another approach to generating shear-thinning supramolecular hydrogels is incorporating UPy 
modified with bulky, hydrophobic adamantyl groups, instead of alkyl spacers, to create 
“hydrophobic pockets” that shield the hydrogen bonds from solvent interactions[67] and act to 
stabilize the structure, resulting in a self-healing and viscoelastic hydrogel that retains its rheological 
characteristics post injection. This material is likely non-toxic but its suitability for tissue engineering 
may be limited due to rapid erosion because of progressive solubilization in highly aqueous 
environments and requires further testing. 




 Figure 2. In vivo testing of Dex-UPy hydrogel for bone and cartilage tissue regeneration. a) 
Schematic illustration of self-integration and the application in cartilage–bone tissue complex 
regeneration. Hydrogels encapsulating chondrocytes (blue) and BMSCs/BMP-2 (red) were integrated 
into a construct and then implanted subcutaneously in a nude mouse to form the cartilage–bone 
tissue complex. (b-e) Subcutaneous implantation of the cell-gel constructs. b) A section of 
BMSCs/BMP-2 only group, stained with Alizarin red (positive staining represents mineralized bone 
tissue). c) A section of chondrocytes only group, stained with Alcian blue (positive staining 
represents cartilage tissue). d) A section of the self-integrated group, stained with both Alizarin red 
and Alcian blue. e) A magnified image of the interface region of image ‘c’. 
Adapted with permission. [41] 2015, Wiley. 
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2.2.2. Benzene-1,3,5-tricarboxamide 
More recently, benzene-1,3,5-tricarboxamide (BTA)[68,69] has been recognized as a useful multiple 
hydrogen bonding unit for formation of supramolecular hydrogels. BTA is a disk-shaped molecule 
functionalized with hydrophobic alkyl spacers and oligo(ethylene glycols) to increase solubility in 
polar solvents, such as water.[68] In water, BTA uses a combination of its three-fold hydrogen 
bonding, protective hydrophobic pocket, and π-π interactions between  
 
the benzene rings to self-assemble into helical fibers (Figure 3).[70,71] At high enough concentrations, 
BTA based hydrogels form as a result of crosslinking of telechelic BTAs, and much like UPy based 
hydrogels, are very sensitive to the ratio between hydrophobic and hydrophilic spacers.[59,69,70,72] 
Recently, this method of self-assembly has received increased attention, and has been combined 
with principles of DNA-origami to enable precise control over the spatial distribution and 
recruitment of proteins in adaptive scaffolds. Most recently, self-assembly of BTA monomers were 
used to form one-dimensional supramolecular polymers that allow facile incorporation of various 
and DNA-functionalized BTA monomers that enabled efficient and dynamic control of protein 
activity along the polymer.[72–75] Functional BTAs have been incorporated into hydrogels for siRNA 
capture that represent a versatile platform for further development of various functionalized BTA 
polymers.[76] While promising and well characterized, these materials have yet to be tested in vitro 
for cytotoxicity and have not been developed towards use in regenerative medicine. 
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Figure 3. a) Structure of BTA1. R,R’R’’ are alkyl chains/other substituents. b) Three-fold hydrogen 
intermolecular bonding and helical assembly of BTA.  
3B: Adapted with permission from P.J.M. Stals, J.F. Haveman, A.R.A. Palmans, A.P.H.J. Schenning, J. 
Chem. Educ. 2009, 86, 230.  Copyright 2009, American Chemical Society. 
 
  
A                B 
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2.2.3. Other Hydrogen Bonding Motifs  
Poly(vinyl alcohol) may also form pH-sensitive self-healing hydrogels based on hydrogen bonding 
and, to a lesser degree, hydrophobic interactions.[77] These materials do not retain their mechanical 
properties upon re-integration, but hold promise for drug delivery systems for cancer therapy, and 
require further investigation.[78] While non-UPy  hydrogen bonding moieties remain largely un-
utilized in tissue engineering applications, they offer alternative routes to formation of self-healing 
hydrogels, and the novel chemistries described here hold promise for advancing the field in new 
directions.   
2.3. Macrocyclic Host-Guest Interactions and Inclusion Complexes  
One of the most studied non-covalent methods for formation of supramolecular hydrogels is host-
guest interactions based on macrocyclic compounds such as cyclodextrins (CDs), cucurbit[n]urils, 
crown ethers, catenanes, and cyclophanes. This review will focus on self-healing supramolecular 
hydrogels based on CDs and their derivatives. A comprehensive review of supramolecular host-guest 
systems for biological applications can be found in the literature.[79,80] 
2.3.1. Cyclodextrin Derivatives  
CDs are a family of oligosaccharides first discovered in the late 19th century and have a long history 
of use in biological applications due to their superior biocompatibility, unique inclusion capability 
and ease of functionalization.[81–83]  They have a truncated 3D cone shape with a hollow, tapered 
inner cavity and a fixed length (0.79nm).[84] The width of CDs may be increased with the number of 
glucose repeat units, connected by α-1,4 glycosidic linkages (Figure 4).[80] Since their discovery, α-, β-, 
and γ-CDs, composed of 6, 7, and 8 glucose units respectively, have emerged as the most commonly 
used members of the CD family.[80]  
  




Figure 4. Molecular structures and dimensions of various CDs: A, α-CD; B, β-CD; and C, γ-CD. 
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Members of the CD family have been successfully used as building blocks for self-healing hydrogels 
capable of stimuli-responsive self-assembly based on host-guest interactions between CDs and 
polymers.[84] Most often, poly(ethylene oxides) or block copolymers are used to further strengthen 
the hydrogels with hydrophobic segments that experience intermolecular hydrophobic 
interactions.[85,86] These supramolecular hydrogels have also been incorporated with covalent 
bonding to form materials systems with unique chemistry not seen in other supramolecular systems. 
[87] High molecular weight PEG was first reported to be able to form inclusion complexes with α-CD 
to assemble into supramolecular hydrogels.[88] Since then, the method of threading CDs onto linear 
hydrophilic polymers to form a hydrogel has been used to create supramolecular hydrogels (Figure 
5a). [89–91] The dominant driving force in most host-guest systems are hydrophobic interactions that 
combat competitive water to drive self-assembly. Aside from inclusion complex formation, 
supramolecular hydrogels have been formed through co-assembling hydrophobically-modified 
polymers with polymers containing pendant CDs (Figure 5b). [85,92] Another promising strategy is the 
preparation of supramolecular ‘monomers’ with host-guest functionality and subsequent 
polymerization using various techniques. Host- and guest-containing CD monomers were 
polymerized via radical polymerization to form poly(acrylamide) chains which then formed inclusion 
complexes with CDs from nearby polymer chains to assemble a self-healing hydrogel network. [93] 
Although the crosslinking conditions are mild, and it exhibits an unusual ability to retain its 
mechanical integrity upon complete rejoining, acrylamide monomers are highly cytotoxic [94], so the 
utility of the hydrogel may be limited. More recently, a modified β-CD host molecule was developed 
that forms an inclusion complex to make three-arm host-guest supramolecules.[95] This ‘monomer’ 
unit was subsequently polymerized using UV light, creating a non-cytotoxic self-healing hydrogel due 
to reversible self-integration of the free supramolecular host-guest units.[95] These hydrogels have 
been tested in soft tissue engineering but have yet to be translated to in vivo studies.  In another 
promising application towards soft tissue engineering, a hyaluronic acid-adamantane and β-CD 
hydrogel construct was tested with secondary autonomous covalent crosslinking for regeneration of 
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myocardial tissue post infarct.[96] After injection, this material acted as a support scaffold after injury 








Figure 5. Two different approaches for utilizing host-guest interactions to form supramolecular 
hydrogels. a) Fabrication of hydrogels based on inclusion complexes between CDs and various 
polymers that can thread into CD cavities. b) Supramolecular hydrogels formed by physical cross-
linking through host–guest interactions between CD-containing polymers and hydrophobically 
modified polymers. 
Adapted with permission under the terms of 4440310602787 License[64] 2013, Elsevier B.V.  
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CD-containing supramolecular hydrogels are promising alternatives to covalently crosslinked 
hydrogels as injectable materials for drug and gene delivery. Many hydrogels that require covalent 
crosslinking for gelation are limited in application as they are not injectable, and it is time-consuming 
and inefficient to incorporate drugs by sorption, limiting the loading. [97] Additionally, it can require 
delicate bioactive agents such as drugs, proteins, RNAs, and DNAs be exposed to organic solvents 
which may alter their chemical integrity. [97] Therefore, the development of a system capable of 
simultaneous gelation and drug loading in aqueous environment without covalent crosslinking is 
highly desired. One such system uses supramolecular hydrogel formed by CD-polymer inclusion 
complexes[98] has been developed as an injectable drug delivery device, but work remains to be done 
towards its in vivo usage.  
Given the biocompatibility, shear-thinning, and self-healing nature of CD-based hydrogels, it is 
logical to extend their use towards 3D bioprinting. 3D bioprinting combines cells with a shear-
thinning and self-recovering hydrogel to mimic native tissue characteristics and has received 
increased attention in recent years. A host-guest hydrogel using hyaluronate modified with 
adamantane and β-CD was developed that self-assembles into a shear-thinning hydrogel.[99] To 
increase its long-term stability and profusion, this hydrogel may be designed to undergo a secondary 
covalent UV crosslinking while maintaining its injectability. This system is an exciting step towards 3D 
bioprinting for tissue regeneration, as it was shown to have high (>90%) cell viability and the 
incorporation of cells did not disrupt or alter the printing process besides necessitating sterility. In 
the coming years, the use of self-healing supramolecular hydrogels will continue to develop and 
further bioprinting for tissue engineering.   
2.3.2. Stimuli-Responsive Cyclodextrin Derivatives  
In addition to autonomous assembly via inclusion complex formation, CDs can be utilized in various 
self-healing stimuli-responsive applications including thermo-responsive, redox and photo-switching, 
leading to interesting properties such as shape-memory[100] hydrogels and precise spatiotemporal 
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control over size and stiffness of the hydrogel.[101] Stimuli-responsive CDs are useful in the 
construction of tissue engineering complexes (scaffold, cells, and/or signaling molecules) with 
various applications including engineering artificial muscle[102], cardiac tissue regeneration[96], 
anticancer drug delivery[103,104], and delivery of biologics.[105] These functionalities have been used 
towards development of ‘smart’ hydrogels that respond to their environment, enabling better drug 
delivery and tissue mimicry. Ferrocene (FC) and its derivatives are widely used as redox-responsive 
molecules in supramolecular chemistry applications, adding stimuli-responsiveness while preserving 
the bulk properties.[106]  For example, a self-healing supramolecular hydrogel where poly(acrylic acid) 
(PAA) modified with β-CD and a PAA-FC guest polymer undergoes redox-responsive self-healing 
based on formation of inclusion complexes has been reported.[102] This work is promising for future 
applications in stimuli-responsive drug delivery to tissues with a low local pH such as tumors, 
although cell toxicity and drug encapsulation have not been verified. Separately, a non-cytotoxic 
hydrogel system that is dually electrochemical and redox responsive was synthesized via formation 
of host–guest interactions between β-CD and FC and exhibits rapid self-healing capabilities.[107]  This 
work is promising, but may be improved by incorporating controlled drug or biologic delivery 
systems, as is often required for effective tissue regeneration. Inclusion complexes formed by trans-
azobenzene and β-CD as a photo-switchable crosslinker have been used to create a dextran based 
hydrogel system for light controlled release of DNA and proteins.[105] Azobenzene is a photo-sensitive 
moiety that enables reversible sol-gel transitions, and although it remains largely unutilized in tissue 
engineering applications, it was shown in this work to be part of a system that was not harmful to 
biologics.[108,109] While UV irradiation may be harmful to tissues, the tight spatiotemporal control 
achieved makes it a promising stimulus for crosslinking in tissue engineering applications.[110] Given 
their high modularity, CDs are excellent candidates for development of highly stimuli-responsive 
hydrogels for tissue engineering.  
2.4. Hydrophobic Interactions  
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Hydrophobic interactions are one of the most important driving forces in the supramolecular 
assembly of tissue engineering complexes.[111] They can form physical crosslinks between polymer 
chains, which are highly important in self-assembly of biological materials such as fibrillar proteins, 
or cause the association and subsequent self-assembly of supramolecular polymer fibers.[112] 
Hydrophobic interactions are driven by the entropic gain that follows from burying the hydrophobic 
faces of molecules away from the aqueous environment of the swollen hydrogel bulk and the 
subsequent release of surface-bound water, a large net entropic gain with a small enthalpy 
penalty.[113] This type of physical crosslinking can be combined with hydrogen bonding as in UPy and 
BTA where it acts as a protective pocket for the hydrogen bonds, and host-guest interactions. It is 
often combined with chemical crosslinking to enhance the mechanical properties of the resulting 
gels, and unlike other supramolecular motifs, can be utilized to generate tough, self-healing 
hydrogels.[114,115]  
2.4.1. Peptides and Peptide Amphiphiles 
Due to their inherent bioactivity and biocompatibility, peptides are excellent choices for use in 
biodegradable supramolecular hydrogel building blocks.[28] Peptide amphiphiles with hydrophilic 
peptide segments covalently bonded to long hydrophobic polymer tails have been widely used to 
construct self-assembling, bioactive supramolecular materials.[116,117] Peptide amphiphiles (PA), 
consisting of a peptide(s) covalently bonded to a carefully designed synthetic polymer, have been 
developed into self-assembling hydrogels.[118] Supramolecular fibers formed from self-assembly of 
PAs have been shown to allow bioactive cues such as the fibronectin-derived RGD peptide to freely 
move along the backbone of the fiber to attain optimal and dynamic RGD spacing, a benefit over 
covalent polymers, where the spacing and concentration of RGD must be strictly controlled. [119] Due 
to the biodegradability and non-toxic nature of PA hydrogels, they have been extensively studied for 
3D cell culture. For example, di-block co-polypeptide amphiphiles that self-assemble into rapidly 
self-healing, degradable, and functional hydrogels have been synthesized that have potential in 
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biomedical applications.[120] Once injected, these supramolecular hydrogels aid in establishing a 
preferential environment for therapeutic cells, and can direct them towards the desired lineage. For 
example, the self-assembly of amyloid fibers was utilized to develop a tunable, self-healing, thermo-
responsive hydrogel that promoted cell attachment, spreading, and differentiation towards a 
neuronal lineage.[121] This gel is non-toxic in various cell lines, an important step towards utilization in 
vivo. Additionally, both in vitro and in vivo differentiation of mesenchymal stem cells into 
chondrocytes without the use of exogenous growth factors was reported in hyaluronate and heparin 
mimicking PA hydrogels. [122]  
Work has been done to improve the encapsulation of hydrophobic drugs in PA-based materials for 
drug delivery purposes. To this end, aliphatic chains have been added to peptide nanofibers to 
enhance the solubility of hydrophobic drugs even in the aqueous environment, allowing their use as 
efficient drug delivery vehicles, however these self-assembling nanofibers were not able to form 
hydrogels.[123] Later work developed a smart peptide-based logic-gate hydrogel that can sense 
various biological disease markers and can be programmed for controlled drug release, answering 
both the need for hydrophobic drug delivery and stimuli-responsive injectable hydrogel scaffolds.[124]  
Although these works represent important steps towards clinical application of PA hydrogels, the 
many advances made with PA nanofibers have yet to be incorporated into hydrogels for tissue 
engineering.   
The bioactive properties of self-healing peptide-based hydrogels have also been used to good effect 
in the regeneration of hard tissues including bone,[125] cartilage,[126] and dental tissue[127], which 
represents a deviation from traditional approaches to engineering of hard tissues. Self-assembling 
PAs have been used for dual delivery of dental stem cells and growth factors to regenerate 
dentin.[118,127] Upon inclusion of a MMP-cleavable linker within the peptide sequence, enhanced 
viability, spreading, and migration of human mesenchymal stem cells was observed.[128] This material 
lacks the ability to completely self-heal, as the MMP-cleavable linkers are permanently cut during 
 This article is protected by copyright. All rights reserved.- 24 - 
cell invasion,[118,127] however, PAs with repeated self-healing abilities have also been explored for 
regeneration of nerves[129] and angiogenesis.[130]  
In addition to bone and dental engineering, recent advances have shown the potential for self-
healing peptide-based supramolecular hydrogels to improve outcome in cardiovascular disease 
models by both improving angiogenesis and regenerating or attenuating damage to cardiac tissue 
following injury. These hydrogels represent a promising low-dose delivery system for growth factors 
given their many available binding sites and biocompatibility. [29] These materials have also been used 
for their advantageous mechanical properties and as delivery devices for cells to contribute to 
modest regeneration of functional cardiovascular tissue. [131,132] While they exhibit many 
advantageous properties, peptide-based systems also have drawbacks including their high costs, 
potential difficulty with scale-up, and less-controllable enzymatic degradation.[133] 
2.4.2. Amphiphilic Block Copolymers 
Although PAs are biocompatible and bioactive, due to the expense of large scale peptide production, 
it became necessary to develop cost-effective, scalable systems. Amphiphilic block copolymers that 
self-assemble based on hydrophobic interactions[134] have been utilized for drug delivery[135,136], cell-
encapsulation[137], cartilage regeneration[122], and 3D bioprinting.[138] Recently, an injectable star PEG-
b-poly (propylene sulfide) scaffold for wound repair was reported.[139] These hydrogel matrices self-
assemble in aqueous media and effectively dissolve hydrophobic molecules, enabling local delivery 
of therapeutic doses of small molecules. Ultimately, these scaffolds improved cellular infiltration, 
reduced inflammation, and promoted wound closure in vivo, representing one of the few systems 
whose suitability for clinical translation has been tested.  
2.5. Electrostatic (Ionic) Interactions 
Ionically cross-linked hydrogels are biocompatible and self-healing based on the mild conditions and 
reversibility of their gelation, which is due to the electrostatic interaction between oppositely 
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charged ions within the constituent materials.[140] Alginate, a naturally occurring, anionic, and 
hydrophilic polymer forms a crosslink in the presence of cations, most typically Ca2+, and is the most 
well-studied ionically cross-linked polymer for tissue engineering.[141–144] Initial hurdles to its use, 
including control of gelation rate, and lack of uniform structure have been addressed.[140,145] A 
comprehensive review of ionically cross-linked alginate hydrogels and their applications to 
biomedical engineering can be found in the literature.[141]  
Various groups have introduced ionically cross-linked hydrogels with increased mechanical strength 
and toughness, addressing a known drawback of these types of hydrogels.[146,147] Recently, 
hyaluronate-based hydrogels have been explored as scaffolds for injectable cell delivery, an 
important area of development in tissue engineering.[148] Other materials such as PEG and clay have 
also been used to prepare ionically crosslinked hydrogels with unique properties and potential 
applications in tissue engineering, however, it should be noted that most ionically crosslinked 
hydrogels are not inherently self-healing and often require many modifications to achieve this 
property.[149,150]  
2.6. Metal Coordination 
Metal-ligand coordination plays a critical role in adhesion, self-assembly, and toughness in many 
biological materials.[151] Metal–ligand complexation has been widely utilized in the formation of 
supramolecular self-healing hydrogels owing to their high stability, rapid self-assembly, relatively 
high bonding energies, and the ease of incorporating biocompatible polymers.[152–154] A 
supramolecular metal-ligand complex is formed between a transition metal ion and the electron-
donating organic ligand to enable a rapidly reversible and spontaneous linkage, the stability of which 
varies based on metal-ion concentration and pH.[152,155] With careful selection of the metal-ligand 
pair, supramolecular hydrogels with many advantageous near-covalent mechanical properties may 
be developed.[20] Researchers have sought to mimic the viscoelasticity and the partial recovery of the 
Young’s Modulus that leads to the acellular self-healing abilities displayed by mussel byssal 
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threads.[153] The histidine-metal coordination acted as a sacrificial bond to dissipate energy and 
reformed upon removal of the applied load. Apart from histidine, the pH-induced Fe3+-catechol 
crosslinking pair has been used to generate self-healing supramolecular hydrogels that achieve near-
covalent elastic moduli.[156] This work establishes a method for decoration of hydrophilic polymers 
with metal-coordinating ligands but does not offer insight into their suitability for biomedical 
applications. Subsequent work in the area resulted in histidine-based metal coordination hydrogels 
made with PEG which establishes a robust self-healing biomaterial with mechanical properties 
comparable to native soft tissues.[153] These monovalent systems were not designed for tissue 
engineering, and as such their biocompatibility has not been fully evaluated and their stability in vivo 
is likely low, making them less useful for longer-term applications.[157] Recently, an injectable 
hydrogel that uses reversible poly-histidine-Ni coordination bonds has been used to make a 
multivalent biomaterial stable enough for use in sustained drug delivery systems but its in vivo 
suitability is yet to be proven.[158]  
Other ligands for metal coordination hydrogels have been developed including terpyridine, a 
pyridine derivative commonly used to form directed and stable but reversible complexes with a 
variety of metal ions in biocompatible hydrogels, however, these remain largely unproven in tissue 
engineering systems.[159] Although not intended for tissue engineering, a conductive, self-healing 
hybrid hydrogel has been reported which has potential for prostheses given its conductivity, 
enhanced mechanical properties, and elasticity.[160] Metal-ligand coordination-based hydrogels offer 
unique materials with potential to achieve high elastic moduli while maintaining their self-healing 
properties and represent an interesting class of biomaterials for tissue engineering.  
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3. Conclusions and Outlook  
Recent innovations in supramolecular chemistry and biology, including a more complete 
investigation of ECM properties on cell fate and function, scaffold effects, and growth factors, have 
been incorporated into supramolecular hydrogel design to develop novel biomaterials with self-
healing capabilities that are very useful in tissue engineering.  These materials have been explored 
for 3D culture of various cell types as well as regeneration of dental and bone tissue in addition to 
soft tissue engineering including dental pulp, cartilage, and cardiovascular tissues.  
Looking forward, major advances in self-healing supramolecular hydrogels will come from the 
continued incorporation of novel chemistries into biocompatible hydrogels that can advantageously 
recapitulate native tissue architecture and offer controlled delivery of cells and signaling cues. 
Specifically, supramolecular ‘monomer’ units will continue to be developed that direct 
spatiotemporal control of drugs and biologics. Structural, mechanical, and dynamic behavior is a 
hallmark of native tissue, and one of the most difficult aspects to mimic given the large range of cell 
types and tissue systems. One could envision that future ‘smart’ materials would be able to not only 
react to stimuli but respond and adapt to mechanical and biological changes in the scaffold, 
controlling release of drugs and biologics in advantageous spatiotemporal patterns over a controlled 
timeframe. In addition to materials chemistry, cell adhesion is critical to cell infiltration and 
therefore to tissue integration, a goal for many tissue engineering constructs.  
The mechanical properties of these soft hydrogels may need to be improved for applications that 
require stiffer scaffolds, a slower rate of erosion and clearance, repeated self-healing or a 
combination thereof. This may be achieved by the advent of biomaterials that repeatedly self-heal 
under physiological conditions, allowing sustained release of drugs and biologics as well as the 
retention of bulk properties.  
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Many currently available supramolecular hydrogels, although they have been extensively 
characterized, have yet to be tested in vivo, and in some cases, have not yet been evaluated in vitro, 
meaning their suitability for clinical application is to be determined. The development of future 
hydrogel biomaterials for tissue engineering purposes should include studies on biocompatibility and 
host integration, including potential immune response, to enable regeneration or complete 
replacement of lost or damaged tissues, eventually leading to improved patient outcomes and 
quality of life. 
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Table 1.  
 
Supramolecular Category Specific Bonding Motif Section References 
Hydrogen Bonding 
Ureidopyrimidinone 2.2.1 31, 48, 56-67 
Benzene-1,3,5-
tricarboxamide 
2.2.2 59, 68-76 
Others 2.2.3 77, 78 
Macrocyclic Host-Guest and 
Inclusion Complexes 
Cyclodextrin Derivatives 2.3.1 80-96, 98,99 
Stimuli-Responsive 
Cyclodextrins 
2.3.2 100-105, 106-110 
Hydrophobic Interactions 




Electrostatic Interactions  2.5 140-150 
Metal-Ligand Complexation  2.6 20, 151-160 
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Figure 1. Design of a Dextran-UPy hydrogel for multi-tissue regeneration. a) Schematic illustration of 
Dex-UPy hydrogel formation and the mechanisms of the shear-thinning and self-recovery properties. 
Top: multiple hydrogen bonds of UPy and their dynamic interactions. Bottom: hydrogel network 
formation through UPy hydrogen bonds, the shear- thinning under shear stress and self-recovering 
of the hydrogel. b) Self-integration of the hydrogel pieces to form various structures. Some hydrogel 
disks were dyed pink with rhodamine and the others were left with the original light-yellow color to 
visualize the interfaces. Scale bar = 5 mm. 
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Figure 2. In vivo testing of Dex-UPy hydrogel for bone and cartilage tissue regeneration. a) Schematic 
illustration of self-integration and the application in cartilage–bone tissue complex regeneration. 
Hydrogels encapsulating chondrocytes (blue) and BMSCs/BMP-2 (red) were integrated into a 
construct and then implanted subcutaneously in a nude mouse to form the cartilage–bone tissue 
complex. (b-e) Subcutaneous implantation of the cell-gel constructs. b) A section of BMSCs/BMP-2 
only group, stained with Alizarin red (positive staining represents mineralized bone tissue). c) A 
section of chondrocytes only group, stained with Alcian blue (positive staining represents cartilage 
tissue). d) A section of the self-integrated group, stained with both Alizarin red and Alcian blue. e) A 
magnified image of the interface region of image ‘c’. 
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Figure 4. Molecular structures and dimensions of various CDs: A, α-CD; B, β-CD; and C, γ-CD. 








Figure 5. Two different approaches for utilizing host-guest interactions to form supramolecular 
hydrogels. a) Fabrication of hydrogels based on inclusion complexes between CDs and various 
polymers that can thread into CD cavities. b) Supramolecular hydrogels formed by physical cross-
linking through host–guest interactions between CD-containing polymers and hydrophobically 
modified polymers. 
Adapted with permission. [64] 2013, Elsevier B.V.  
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Self-healing supramolecular hydrogels are a novel class of biomaterials that offer unique 
advantages in tissue engineering. This review describes important methods of supramolecular 
hydrogel formation as well as recent advances and emerging applications of these hydrogels in 
regenerative medicine. 
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